Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer:: reduced expression of PPARγ-coactivator 1 (PGC-1)

被引:89
作者
Feilchenfeldt, J
Bründler, MA
Soravia, C
Tötsch, M
Meier, CA
机构
[1] Univ Hosp Geneva, Dept Med, Div Endocrinol & Diabet, Endocrine Unit, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Dept Pathol, Div Clin Pathol, CH-1211 Geneva, Switzerland
[3] Univ Hosp Geneva, Clin Digest Surg, Dept Surg, CH-1211 Geneva 14, Switzerland
关键词
peroxisome proliferator-activated receptor; 9-cis retinoic acid receptor; PPAR gamma-coactivator-1; colorectal cancer;
D O I
10.1016/j.canlet.2003.08.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) alpha,beta/delta and gamma are fatty acid sensitive transcription factors that have been implicated in colorectal cancer. To better understand their role, we studied the expression levels of all PPAR-isoforms and transcriptional partners such as the retinoid X receptor alpha (RXRalpha) and PPARgamma-coactivator-1 (PGC-1) by means of real-time patients with colon cancer. While a heterogeneous pattern was observed for the expression level of the PPAR-isoforms alpha,beta/delta and gamma, the coactivator PGC-1 was significantly decreased in 15 of 17 tumors. Taken together our data suggest that the transcriptional activity of PPARgamma may not only be decreased by mutation but also by downregulation of the coactivator PGC-1 of PPARgamma. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 39 条
  • [1] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [2] Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
    Barak, Y
    Liao, D
    He, WM
    Ong, ES
    Nelson, MC
    Olefsky, JM
    Boland, R
    Evans, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) : 303 - 308
  • [3] Bautista S, 1998, CLIN CANCER RES, V4, P2925
  • [4] Bièche I, 1999, CANCER RES, V59, P2759
  • [5] A decade of molecular biology of retinoic acid receptors
    Chambon, P
    [J]. FASEB JOURNAL, 1996, 10 (09) : 940 - 954
  • [6] The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
    Chung, DC
    [J]. GASTROENTEROLOGY, 2000, 119 (03) : 854 - 865
  • [7] Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
    Demetri, GD
    Fletcher, CDM
    Mueller, E
    Sarraf, P
    Naujoks, R
    Campbell, N
    Spiegelman, BM
    Singer, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3951 - 3956
  • [8] CONTROL OF THE PEROXISOMAL BETA-OXIDATION PATHWAY BY A NOVEL FAMILY OF NUCLEAR HORMONE RECEPTORS
    DREYER, C
    KREY, G
    KELLER, H
    GIVEL, F
    HELFTENBEIN, G
    WAHLI, W
    [J]. CELL, 1992, 68 (05) : 879 - 887
  • [9] The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers
    DuBois, RN
    Gupta, R
    Brockman, J
    Reddy, BS
    Krakow, SL
    Lazar, MA
    [J]. CARCINOGENESIS, 1998, 19 (01) : 49 - 53
  • [10] The organization, promoter analysis, and expression of the human PPAR gamma gene
    Fajas, L
    Auboeuf, D
    Raspe, E
    Schoonjans, K
    Lefebvre, AM
    Saladin, R
    Najib, J
    Laville, M
    Fruchart, JC
    Deeb, S
    VidalPuig, A
    Flier, J
    Briggs, MR
    Staels, B
    Vidal, H
    Auwerx, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18779 - 18789